These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31444669)

  • 1. Low-Frequency Sonophoresis of Chinese Medicine Formula Improves Efficacy of Malignant Pleural Effusion Treatment.
    Tian AP; Yin YK; Yu L; Yang BY; Li N; Li JY; Bian ZM; Hu SY; Weng CX; Feng L
    Chin J Integr Med; 2020 Apr; 26(4):263-269. PubMed ID: 31444669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients.
    Han L; Jiang Q; Yao W; Fu T; Zeng Q
    BMC Cancer; 2018 Jul; 18(1):725. PubMed ID: 29980186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis.
    Wang CQ; Xu J; Jiang H; Zheng XT; Zhang Y; Huang XR; She F; Fan TY; Zhan L; Feng JH; Gong QH; Xiao X; Chen XF; Xiao Z
    Phytomedicine; 2023 Jul; 115():154847. PubMed ID: 37149965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Controlled Study to Observe the Efficacy of External Treatment With a Traditional Chinese Medicine Herbal Ointment on Malignant Plural Effusion: Outcome Report and Design Review.
    Feize W; Meng L; Yanni L; Yuan L; Liqun J; Tong L; Guowang Y; Huijuan C; Donggui W; Zhiqiang C; Lei Z
    Integr Cancer Ther; 2017 Dec; 16(4):473-478. PubMed ID: 27431570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion.
    Fuhong D; Xiang G; Haiying L; Jiangye W; Xueming G; Wenxiao C
    BMC Cancer; 2018 Apr; 18(1):411. PubMed ID: 29649989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of intrapleural pingyangmycin administration on activity of fibrinolytic system and transforming growth factor-beta1 in malignant pleural effusion].
    Zhu QQ; Sun GY
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):674-8. PubMed ID: 20079281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
    Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M
    Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
    Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
    Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, phase III, double-blind, placebo-controlled trial of intrapleural instillation of methylprednisolone acetate in the management of malignant pleural effusion.
    North SA; Au HJ; Halls SB; Tkachuk L; Mackey JR
    Chest; 2003 Mar; 123(3):822-7. PubMed ID: 12628884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
    Kang MQ; Cao YP; Deng F
    Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection.
    Congcong Q; Hengting Z; Shuhui L; Fang Y; Shan W
    Am J Med Sci; 2019 Dec; 358(6):400-411. PubMed ID: 31813467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical observation on the efficacy of Xiaoshui decoction combined with intrapleural perfusion of cisplatin in treating malignant pleural effusion.
    SHI Z; HE QY; HUA BJ
    Chin J Integr Med; 2008 Dec; 14(4):257-61. PubMed ID: 19082796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese medicine Xiaoshui decoction inhibits malignant pleural effusion in mice and mediates tumor-associated macrophage polarization by activating autophagy.
    Jin Z; Shen C; Zhang H; Qi R; Guo Q; Liu R; Hua B; Shi Z
    J Ethnopharmacol; 2020 Mar; 249():112412. PubMed ID: 31751649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal extract elemene intrathoracic injection in the treatment of lung cancer patients with malignant pleural effusion: a meta-anaylsis.
    Chen J; Chen YJ; Wu MD
    J Cancer Res Ther; 2014 Aug; 10 Suppl 1():56-9. PubMed ID: 25207893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhu G; Wang X; Li J; Zhang Y; Gao R; Zhang X; Xu B; Hu J; Dai M; Chen J
    Front Pharmacol; 2021; 12():694129. PubMed ID: 34803667
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
    Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
    Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol of a phase 1 clinical trial establishing the safety of intrapleural administration of liposomal curcumin: curcumin as a palliative treatment for malignant pleural effusion (IPAL-MPE).
    Hocking AJ; Farrall AL; Newhouse S; Sordillo P; Greco K; Karapetis CS; Dougherty B; Klebe S
    BMJ Open; 2021 Mar; 11(3):e047075. PubMed ID: 33782024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin.
    Jiang L; Li P; Gong Z; Hu B; Ma J; Wang J; Chu H; Zhang L; Sun P; Chen J
    Anticancer Res; 2016 Mar; 36(3):1313-8. PubMed ID: 26977031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion.
    Jones DR; Taylor MD; Petroni GR; Shu J; Burks SG; Daniel TM; Gillenwater HH
    J Thorac Oncol; 2010 Jan; 5(1):75-81. PubMed ID: 19884858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.